Press & MEdia


events & presentations


financial information


Our Mission

Our mission is to improve outcomes for potential lung cancer patients through early predictive technologies, provide cost savings to patients, payers, and providers, and to provide a fair return on investment to shareholders and other stakeholders.

ProLung is committed to making a positive and significant impact on the healthcare community and to being socially responsible in all its endeavors.


Investor Relations Contact

Zimmons International Communications, Inc.
Jennifer K. Zimmons, Ph.D.